Stemrad

Stemrad

Stemrad develops personal protective equipment for protection against the effects of acute radiation syndrome and sickness. Learn more
  • Edit
DateInvestorsAmountRound

$1.0m

Series B
*

$6.0m

Series C

$250k

Grant

N/A

Series C
Total FundingAUD11.2m

Recent News about Stemrad

Edit
More about Stemradinfo icon
Edit

StemRad specializes in advanced radiation protection solutions designed to safeguard astronauts, military personnel, and first responders from harmful radiation exposure. Operating in the defense, aerospace, and emergency services markets, StemRad's core product leverages the regenerative capabilities of stem cells by selectively shielding bone marrow and other stem cell-rich organs in the abdominal and pelvic regions. This approach ensures effective protection while maintaining mobility, unlike traditional whole-body shielding which is often cumbersome and less effective against penetrating radiation like gamma rays. The company generates revenue through the sale of its specialized protective gear to government agencies, space organizations, and emergency response units. StemRad's business model focuses on innovation and strategic partnerships, including collaborations with NASA and other defense entities. Key clients include astronauts, military units, and emergency response teams who require reliable and mobile radiation protection solutions.

Keywords: radiation protection, stem cells, selective shielding, astronauts, military, first responders, gamma rays, bone marrow, emergency services, aerospace.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.